Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2013 Financial Results

JPMorgan Healthcare Conference 2014

BOSTON--()--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its corporate presentation at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14 at 11:30 a.m. ET. The audio portion of the remarks may be accessed live through Vertex’s website at www.vrtx.com in the “Investors” section under “Events and Presentations”.

In addition, the company announced today that it will report its fourth quarter and full year 2013 financial results on Wednesday, January 29 after the markets close. In conjunction with the announcement, management will host a conference call that day at 5:00 p.m. ET. To participate in the conference call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The call will also be available as a live and archived webcast on Vertex's website at www.vrtx.com in the “Investors” section under “Events and Presentations”.

About Vertex

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of cystic fibrosis, hepatitis C, rheumatoid arthritis and other life-threatening diseases. In addition to our clinical development programs, Vertex has more than a dozen ongoing preclinical programs aimed at other serious and life-threatening diseases.

Founded in 1989 in Massachusetts, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For four years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.

(VRTX-WEB)

Contacts

Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530

Release Summary

Vertex Announces Upcoming Presentation at J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2013 Financial Results

Sharing

Contacts

Vertex Pharmaceuticals Incorporated
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530